Cargando…

Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes

INTRODUCTION: Glaucoma is the second leading cause of vision loss worldwide. The reduction of intraocular pressure remains the backbone of its therapy. Among surgical techniques for its treatment, deep non-penetrating sclerotomy is the most widely practiced non-penetrating surgery. The purpose of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia Barbosa, Renato, Gonçalves, Rita, Bastos, Ricardo, Alves Pereira, Sara, Basto, Rita, Viana, Ana Rita, Tenedório, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257434/
https://www.ncbi.nlm.nih.gov/pubmed/37304331
http://dx.doi.org/10.2147/OPTH.S405837
_version_ 1785057301368930304
author Correia Barbosa, Renato
Gonçalves, Rita
Bastos, Ricardo
Alves Pereira, Sara
Basto, Rita
Viana, Ana Rita
Tenedório, Paula
author_facet Correia Barbosa, Renato
Gonçalves, Rita
Bastos, Ricardo
Alves Pereira, Sara
Basto, Rita
Viana, Ana Rita
Tenedório, Paula
author_sort Correia Barbosa, Renato
collection PubMed
description INTRODUCTION: Glaucoma is the second leading cause of vision loss worldwide. The reduction of intraocular pressure remains the backbone of its therapy. Among surgical techniques for its treatment, deep non-penetrating sclerotomy is the most widely practiced non-penetrating surgery. The purpose of this study was to evaluate the long-term efficacy and safety of deep non-penetrating sclerotomy compared to standard trabeculectomy in patients with open-angle glaucoma. PATIENTS AND METHODS: Retrospective study including 201 eyes with open-angle glaucoma. Closed-angle and neovascular cases were excluded. Absolute success was considered when intraocular pressure under 18 mmHg, or a reduction of at least 20% in patients with a baseline intraocular pressure below 22 mmHg, was obtained after 24 months, without the use of medication. Qualified success was considered when those targets were met with or without the use of hypotensive medication. RESULTS: Deep non-penetrating sclerectomy showed a slightly lower long-term hypotensive effect compared to standard trabeculectomy, with significant differences at 12 months, but not at 24 months of follow-up. The absolute and qualified success rates were 51.85% and 65.43% for the trabeculectomy group and 50.83% and 60.83% for the deep non-penetrating sclerectomy, without significant differences. Regarding postoperative complications, mainly due to postoperative hypotonia, or related to the filtration bleb, they were significantly different between groups, with 10.8% and 24.7%, in deep-nonpenetrating sclerectomy and trabeculectomy groups, respectively. CONCLUSION: Deep non-penetrating sclerectomy seems to be an effective and safe surgical option for patients with open-angle glaucoma unable to be controlled by non-invasive strategies. Data suggests that the intraocular pressure-lowering effect of this technique may be marginally lower than that of trabeculectomy, but the achieved efficacy outcomes were similar, with a significantly lower risk of complications.
format Online
Article
Text
id pubmed-10257434
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102574342023-06-11 Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes Correia Barbosa, Renato Gonçalves, Rita Bastos, Ricardo Alves Pereira, Sara Basto, Rita Viana, Ana Rita Tenedório, Paula Clin Ophthalmol Original Research INTRODUCTION: Glaucoma is the second leading cause of vision loss worldwide. The reduction of intraocular pressure remains the backbone of its therapy. Among surgical techniques for its treatment, deep non-penetrating sclerotomy is the most widely practiced non-penetrating surgery. The purpose of this study was to evaluate the long-term efficacy and safety of deep non-penetrating sclerotomy compared to standard trabeculectomy in patients with open-angle glaucoma. PATIENTS AND METHODS: Retrospective study including 201 eyes with open-angle glaucoma. Closed-angle and neovascular cases were excluded. Absolute success was considered when intraocular pressure under 18 mmHg, or a reduction of at least 20% in patients with a baseline intraocular pressure below 22 mmHg, was obtained after 24 months, without the use of medication. Qualified success was considered when those targets were met with or without the use of hypotensive medication. RESULTS: Deep non-penetrating sclerectomy showed a slightly lower long-term hypotensive effect compared to standard trabeculectomy, with significant differences at 12 months, but not at 24 months of follow-up. The absolute and qualified success rates were 51.85% and 65.43% for the trabeculectomy group and 50.83% and 60.83% for the deep non-penetrating sclerectomy, without significant differences. Regarding postoperative complications, mainly due to postoperative hypotonia, or related to the filtration bleb, they were significantly different between groups, with 10.8% and 24.7%, in deep-nonpenetrating sclerectomy and trabeculectomy groups, respectively. CONCLUSION: Deep non-penetrating sclerectomy seems to be an effective and safe surgical option for patients with open-angle glaucoma unable to be controlled by non-invasive strategies. Data suggests that the intraocular pressure-lowering effect of this technique may be marginally lower than that of trabeculectomy, but the achieved efficacy outcomes were similar, with a significantly lower risk of complications. Dove 2023-06-06 /pmc/articles/PMC10257434/ /pubmed/37304331 http://dx.doi.org/10.2147/OPTH.S405837 Text en © 2023 Correia Barbosa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Correia Barbosa, Renato
Gonçalves, Rita
Bastos, Ricardo
Alves Pereira, Sara
Basto, Rita
Viana, Ana Rita
Tenedório, Paula
Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title_full Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title_fullStr Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title_full_unstemmed Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title_short Trabeculectomy Vs Non‐penetrating Deep Sclerectomy for the Surgical Treatment of Open-Angle Glaucoma: A Long-Term Report of 201 Eyes
title_sort trabeculectomy vs non‐penetrating deep sclerectomy for the surgical treatment of open-angle glaucoma: a long-term report of 201 eyes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257434/
https://www.ncbi.nlm.nih.gov/pubmed/37304331
http://dx.doi.org/10.2147/OPTH.S405837
work_keys_str_mv AT correiabarbosarenato trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT goncalvesrita trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT bastosricardo trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT alvespereirasara trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT bastorita trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT vianaanarita trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes
AT tenedoriopaula trabeculectomyvsnonpenetratingdeepsclerectomyforthesurgicaltreatmentofopenangleglaucomaalongtermreportof201eyes